Celiac Disease in Children

Celiac Disease

Celiac

Disclosure

Stigma, Social

Emotional Problem

Mental Health Wellness 1

Semi-structured, face-to-face interviews will be carried out with participants.

semi-structured interview

Oxford University Hospitals Nhs Foundation Trust

Experiences of Disclosure in Adolescents With Coeliac Disease

Understanding Perceived Barriers to the Disclosure of Psychological Difficulties by Young People With Coeliac Disease

Includes questions around experiences of having coeliac disease and experiences of disclosing psychological difficulties to clinicians in the service.

Data will be kept for 5 years, separately to any identifiable information, and will then be disposed of securely. This is in accordance with Trust policy. The interviews will be deleted when the research study is finished.

University of Oxford

Gluten-free diet adding rusks (100g / day) produced with commercial wheat flour enzymatically treated with mTGasi and lysine ethyl ester.

Gluten-free diet adding rusks (100g / day) produced with untreated wheat flour.

100 g of rusks obtained from commercial wheat flour enzymatically treated with mTGasi and lysine ethyl ester, every day for 3 months

rusks made of wheat flour enzymatically treated

100 g of rusks obtained from commercial wheat flour NOT enzymatically treated with mTGasi and lysine ethyl ester, every day for 3 months

rusks made of wheat flour not enzimatically modified

Gluten-free diet

Sapienza University - Policlinico Umberto I

Wheat Flour Treatment With Microbial Transglutaminase and Lysine Ethyl Ester: New Frontiers in Celiac Disease Treatment.

Wheat Flour Subjected to Microbial Transglutaminase Enzymatic Treatment in the Presence of Lysine Ethyl Ester for Alimentary Use in the Treatment of Celiac Disease.

Proof of any positivization of specific serological antibodies for celiac disease. Results quantified by an ELISA reader at 450 nm (A450nm) is expressed in U/mL and the antibody level 10 U/mL was used as a cutoff value to identify anti-tTG positive results.

Test used to confirm serological activation of celiac disease. IgA EMA were searched in sera diluted 1:5 by indirect immunofluorescence analysis on cryostat sections of monkey esophagus. The results are expressed as ''positive/negative''.

Proof of duodenal mucosa histological alterations induced by celiac disease, consisting in altered (<3:1) villous height/crypt depth ratio and increased (>25) intraepithelial lymphocytes per 100 intestinal epithelial cells, according to Marsh-Oberhuber classification.

Evaluation of bloating intensity is reported according to the Visual Analog or Analogue Scale (VAS), with a range of 0-10.

Evaluation of abdominal pain intensity is reported according to the Visual Analog or Analogue Scale (VAS), with a range of 0-10.

Evaluation of diarrhea intensity is reported according to the Visual Analog or Analogue Scale (VAS), with a range of 0-10.

Evaluation of asthenia intensity is reported according to the Visual Analog or Analogue Scale (VAS), with a range of 0-10.

secale derzhavinii/sveppalyf

Experiences of Disclosure in Adolescents With Coeliac Disease

Wheat Flour Treatment With Microbial Transglutaminase and Lysine Ethyl Ester: New Frontiers in Celiac Disease Treatment.

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum